Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups.
Jean-François YaleUlrik BodholdtAndrei-Mircea CatarigSergiu-Bogdan CatrinaAlice ClarkNeda Rajamand EkbergUmut ErhanPatrick HolmesSøren Tang KnudsenJoanne LiutkusThozhukat SathyapalanBernd SchultesGottfried RudofskyPublished in: BMJ open diabetes research & care (2022)
NCT03457012; NCT03631186; NCT03648281; NCT03876015.